Lista de obras -

Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality

artículo científico publicado en 2016

Ascites: pathogenesis and therapeutic principles.

artículo científico publicado en 2009

Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.

artículo científico publicado en 2014

Bile acids and cardiovascular function in cirrhosis.

artículo científico publicado en 2017

Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis.

artículo científico

Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis

artículo científico

Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study

artículo científico publicado en 2014

Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosis

artículo científico publicado en 2015

Cirrhotic Multiorgan Syndrome

artículo científico

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.

artículo científico publicado en 2013

Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.

artículo científico publicado en 2014

Complications of cirrhosis. A 50 years flashback.

artículo científico

Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study

artículo científico publicado en 2013

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

scientific article published on 02 April 2020

Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers

artículo científico publicado en 2016

Effects of a single dose of terlipressin on transcutaneous oxygen pressures

artículo científico publicado en 2010

Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis

artículo científico publicado en 2010

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.

artículo científico publicado en 2008

Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.

artículo científico publicado en 2014

Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects

artículo científico publicado en 2014

Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects

artículo científico publicado en 2016

Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

artículo científico

Indications for portal pressure measurement in chronic liver disease.

artículo científico publicado en 2012

Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes

artículo científico

Lactate metabolism in chronic liver disease

artículo científico publicado en 2013

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2015

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.

artículo científico publicado en 2016

Low incidence of non-alcoholic steatohepatitis in a Danish liver unit.

artículo científico publicado en 2012

Management of cirrhotic ascites ⬇️

artículo científico publicado en 2015

New insights into cirrhotic cardiomyopathy

artículo científico publicado en 2012

No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion

artículo científico

PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension

artículo científico publicado en 2014

Pathophysiological aspects of pulmonary complications of cirrhosis

artículo científico publicado en 2007

Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.

artículo científico publicado en 2005

Pharmacological approach to acute pancreatitis

scientific article published on May 2008

Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

artículo científico publicado en 2017

Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death

artículo científico publicado en 2016

Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia

artículo científico publicado en 2010

Rifaximin for people with hepatic encephalopathy

artículo científico publicado en 2015

Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial

artículo científico publicado en 2017

Safety and efficacy of Profermin® to induce remission in ulcerative colitis.

artículo científico publicado en 2012

Surgical treatment of diabetes mellitus type 2

artículo científico publicado en 2009

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.

artículo científico publicado en 2007

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

artículo científico publicado en 2016

The cardiorenal link in advanced cirrhosis.

artículo científico publicado en 2012

The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review

artículo científico

Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals ⬇️

artículo científico publicado el 13 de octubre de 2010

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

artículo científico publicado en 2015

Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects

artículo científico publicado en 2016

[Hepatorenal syndrome: diagnosis, treatment and prevention]

artículo científico publicado en 2013

[Treatment of bleeding from oesophageal varices in patients with cirrhosis]

artículo científico publicado en 2007

Lista de obras de

Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality

Ascites: pathogenesis and therapeutic principles.

Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.

Bile acids and cardiovascular function in cirrhosis.

Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis.

Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis

Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study

Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosis

Cirrhotic Multiorgan Syndrome

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.

Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.

Complications of cirrhosis. A 50 years flashback.

Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers

Effects of a single dose of terlipressin on transcutaneous oxygen pressures

Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.

Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.

Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects

Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects

Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Indications for portal pressure measurement in chronic liver disease.

Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes

Lactate metabolism in chronic liver disease

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.

Low incidence of non-alcoholic steatohepatitis in a Danish liver unit.

Management of cirrhotic ascites ⬇️

New insights into cirrhotic cardiomyopathy

No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion

PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension

Pathophysiological aspects of pulmonary complications of cirrhosis

Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.

Pharmacological approach to acute pancreatitis

Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death

Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia

Rifaximin for people with hepatic encephalopathy

Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial

Safety and efficacy of Profermin® to induce remission in ulcerative colitis.

Surgical treatment of diabetes mellitus type 2

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

The cardiorenal link in advanced cirrhosis.

The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review

Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals ⬇️

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects

[Hepatorenal syndrome: diagnosis, treatment and prevention]

[Treatment of bleeding from oesophageal varices in patients with cirrhosis]